METTL3 acts as an oncogene in colorectal cancer via its interaction with the glycolysis components, hexokinase 2 (HK2) and glucose transporter 1 (GLUT1) mRNAs, in an m6A-dependent manner. The gene discussed is HK2; the disease is colorectal cancer.